These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2229922)

  • 1. Modulation of the interleukin 2 receptor by maternal and cord blood serum.
    Vanderbeeken YE; Duchateau J; Van Boogaert L; Desseilles P; Collet H; Lucas A
    Immunopharmacol Immunotoxicol; 1990; 12(2):211-36. PubMed ID: 2229922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of maternal serum on the interleukin2 receptor expression.
    Vanderbeeken YE; Duchateau J; Collet H; Gregoire M; Vandermeersh B; Lucas A
    Immunopharmacol Immunotoxicol; 1992; 14(3):491-513. PubMed ID: 1325491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-2 receptor on cord blood and nulliparous mononuclear cells is downregulated by maternal and cord blood serum.
    Vanderbeeken YE; Duchateau J; Van Boogaert L; Desseilles P; Collet H; Lucas A
    Immunol Cell Biol; 1990 Aug; 68 ( Pt 4)():243-51. PubMed ID: 2249873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional modifications of the CD4+ and the CD8+ subset due to maternal serum.
    Vanderbeeken YE; Duchateau J; Collet H; Van Boogaert L; Desseilles P; Lucas A
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):397-420. PubMed ID: 2516095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the HLA class II antigen at a molecular level by maternal serum.
    Vanderbeeken YE; Duchateau J; Colletl H; Gregoire M; Desseilles P; Lucas A
    Immunopharmacol Immunotoxicol; 1990; 12(4):679-95. PubMed ID: 2092045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of class II histocompatibility antigen expression by maternal serum.
    Vanderbeeken EY; Duchateau J; Vandermeersch B; Collet H; Lucas A
    Dis Markers; 1990; 8(4):199-210. PubMed ID: 1708318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
    Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
    J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the HLA class II antigen at a molecular level by maternal serum among cord blood cells and unrelated lymphocytes.
    Vanderbeeken YE; Duchateau J; Colle H; Gregoire M; Desseilles P; Lucas A
    Arch Gynecol Obstet; 1991; 248(4):199-209. PubMed ID: 1832848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of breast milk of healthy and allergic mothers on in vitro stimulation of cord blood lymphocytes.
    Zizka J; Hrdý J; Lodinová-Zádníková R; Kocourková I; Novotná O; Sterzl I; Prokesová L
    Pediatr Allergy Immunol; 2007 Sep; 18(6):486-94. PubMed ID: 17651385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ovalbumin-specific immunoglobulin G responses during pregnancy reflect maternal intake of dietary egg and relate to the development of allergy in early infancy.
    Vance GH; Grimshaw KE; Briggs R; Lewis SA; Mullee MA; Thornton CA; Warner JO
    Clin Exp Allergy; 2004 Dec; 34(12):1855-61. PubMed ID: 15663559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of interleukin 2 (IL2) receptor expression: IL2 as an inducing signal for the expression of its own receptor on a murine T helper cell line.
    Bismuth G; Moreau JL; Sommé G; Duphot M; Dautry-Varsat A; Robb RJ; Théze J
    Eur J Immunol; 1985 Jul; 15(7):723-7. PubMed ID: 2408903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of some functions of maternal and cord blood lymphocytes.
    Jeanneret I; Fleury S; Girard JP
    Allergol Immunopathol (Madr); 1979; 7(1):29-38. PubMed ID: 474323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique pattern of interleukin 2 receptor expression by lymphocytes in response to anti-Leu 4 monoclonal antibody: relationship to monocyte accessory cell function.
    Prince HE; John JK
    Diagn Immunol; 1986; 4(5):241-6. PubMed ID: 3098490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic action of phorbol ester TPA and calcium ionophore A23187 on human cord and maternal/adult peripheral lymphocytes: regulation by prostaglandin E2.
    Papadogiannakis N; Johnsen SA
    Clin Exp Immunol; 1987 Oct; 70(1):173-81. PubMed ID: 3121221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal fetal immunological relationship particularly mycobacterial immunity.
    Rajajee S; Sundareswar
    Indian Pediatr; 1991 Apr; 28(4):363-6. PubMed ID: 1752653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to cAMP among human cord and maternal/adult peripheral lymphocytes discloses differences between PHA- and OKT3-induced activation pathways.
    Papadogiannakis N; Johnsen SA; Rosberg S; Andersson RG; Olding LB
    Immunology; 1989 Nov; 68(3):378-83. PubMed ID: 2556345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression.
    Iwao Y; Hibi T; Watanabe M; Takaishi H; Hosoda Y; Hayashi A; Ohara M; Ogata H; Aiso S; Toda K
    J Clin Lab Immunol; 1992; 38(1):15-27. PubMed ID: 1343345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.